Milder Donald B's Form 4 filing
Inari Medical, Inc.NARI · filed Nov 8, 2023
- Accession no.
- 0001127602-23-027053
- Filed
- Nov 8, 2023
- Trade date
- Nov 7-8, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $3.00M. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0001127602-24-017129 (May 31, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Milder Donald BCIK 0001279660 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | Common Stock | PPurchaseAcquired | +54,000 | $53.44F1 | +$2,885,760 | 3,029,614 | Indirect | |
| Nov 8, 2023 | Common Stock | PPurchaseAcquired | +2,000 | $53.54 | +$107,080 | 3,031,614 | Indirect | |
| Nov 8, 2023 | Common Stock | PPurchaseAcquired | +100 | $52.23 | +$5,223 | 3,031,714 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $53.13 to $53.79 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.